There are no published randomized controlled trials of BPC-157 in human subjects for any condition not for PCOS, not for gut inflammation, not for any of its widely discussed applications
Evening GLP-1 injections: the case for nighttime dosing Evening dosing has a dedicated following, and the reasoning is surprisingly compelling
Athira Pharma's fosgonimeton (ATH-1017), part of the same HGF/c-Met program, failed the primary endpoint of its Phase 2/3 LIFT-AD Alzheimer's trial in September 2024
I cant stop looking at my face, I cant even cobtrol myself from touch my face even though she said not to
The FDAs 2026 peptide announcement is best understood as a regulatory checkpoint, not a green light
The company has a professional product testing laboratory, each product has a COA quality inspection report, and all saleable goods comply with the report testing